What is it about?

Of 84 eyes (69 patients) with PEHCR referred between 2005 and 2017, the most common referral diagnosis was choroidal melanoma (41.3%). Bilateral involvement was found in 21.7% of cases. Hemorrhagic retinal pigment epithelium detachment was the most common peripheral lesion (53.6%). Maculopathy was associated with peripheral lesions in 65.8% of cases. PEHCR lesions were mostly heterogeneous (58.8%) on B-scan ultrasonography. Choroidal neovascularization was found in 10 eyes (26.3%) out of 38 eyes that underwent fluorescein angiography. Polyps were observed in 14 eyes (58.3%) out of 24 eyes that underwent indocyanine green angiography. Fifty-one eyes were treated (62.2%). Intravitreal injections (IVTI) of anti-VEGF were the most used treatment (36.6%) before laser photocoagulation, photodynamic therapy, vitrectomy and cryotherapy. Only vitrectomy improved visual acuity. Most lesions (65.6%) regressed at the last follow-up visit. Conclusion: In case of PEHCR, multimodal imaging is useful to avoid misdiagnosis, to characterize PEHCR lesions, and guide treatment strategies. Regression of PEHCR lesions was observed in two thirds of the patients. Vitrectomy improved visual acuity. More than a third of patients underwent anti-VEGF IVTI. Further studies are needed to assess IVTI’s efficacy.

Featured Image

Read the Original

This page is a summary of: Diagnosis and treatment of peripheral exudative haemorrhagic chorioretinopathy, British Journal of Ophthalmology, October 2019, BMJ,
DOI: 10.1136/bjophthalmol-2018-313307.
You can read the full text:

Read

Contributors

Be the first to contribute to this page